Category: Cancer Insurance

People seek the unapproved weight loss drug retatrutide online despite FDA approval pending, driven by promising clinical trial results.

Two new FDA-approved oral GLP-1 weight loss pills—Wegovy and Foundayo—offer needle-free alternatives to injectable treatments in 2026, simplifying options for p

Wisconsin APRNs gain independence under the APRN Modernization Act, but Medicare billing remains unclear for these healthcare providers.

Medicare’s 2027 fee schedule may cut payments for same-day care visits, forcing providers to split billing even when combined treatment is medically justified.

Physician moral distress drives exits, with a survey of 1,200 doctors showing 27% have quit and 25% consider leaving, underscored by an Oregon case study.

CMS mandates 5,556 specialists join the new Ambulatory Specialty Model, tying Medicare Part B payments to patient management.

Doctors advise families to limit kids' smartphone time due to health risks, with 40% of children owning tablets by age 2.

Canadians demand healthcare solutions as Parliament resumes. Nearly 90% prioritize universal access amid a shortage of 6.5 million without a family doctor.

Nurses in Ontario protest rising workplace violence after years of assaults, demanding safer conditions and accountability for health-care workers.

Canada drug approval delays leave patients waiting 10-15 years, longer than a moon mission. Discover why new medicines are so slow to reach you.